Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma.

Elif Gülsüm ÜmitUlku KorkmazMehmet BaysalSedanur Karaman GulsaranVolkan BasUfuk DemirciHakkı Onur Kırkızlar Gulay Durmus Altun Ahmet Muzaffer Demir

Published in: European journal of cancer care (2020)

Sarcopenia should be evaluated in every patient and regarded as a treatment target. FDG PET/CT is an easy and handy tool to assess muscle mass and quality as well as MM disease status.

Keyphrases

multiple myeloma
skeletal muscle
case report
insulin resistance
adipose tissue
combination therapy
replacement therapy